Impact of hormonal status on outcome of ductal carcinoma in situ treated with breast-conserving surgery plus radiotherapy: Long-term experience from two large-institutional series.

MLA

Meattini, Icro, et al. “Impact of Hormonal Status on Outcome of Ductal Carcinoma in Situ Treated with Breast-Conserving Surgery plus Radiotherapy: Long-Term Experience from Two Large-Institutional Series.” Breast (Edinburgh, Scotland), vol. 33, June 2017, pp. 139–44. EBSCOhost, https://doi.org/10.1016/j.breast.2017.03.017.

APA

Meattini, I., Saieva, C., Bastiani, P., Martella, F., Francolini, G., Lo Russo, M., Paoletti, L., Doria, M., Desideri, I., Terziani, F., De Luca Cardillo, C., Bendinelli, B., Ciabatti, C., Muntoni, C., Tinacci, G., Nori, J., Smith, H., Brancato, B., Galli, L., … Livi, L. (2017). Impact of hormonal status on outcome of ductal carcinoma in situ treated with breast-conserving surgery plus radiotherapy: Long-term experience from two large-institutional series. Breast (Edinburgh, Scotland), 33, 139–144. https://doi.org/10.1016/j.breast.2017.03.017

Chicago

Meattini, Icro, Calogero Saieva, Paolo Bastiani, Francesca Martella, Giulio Francolini, Monica Lo Russo, Lisa Paoletti, et al. 2017. “Impact of Hormonal Status on Outcome of Ductal Carcinoma in Situ Treated with Breast-Conserving Surgery plus Radiotherapy: Long-Term Experience from Two Large-Institutional Series.” Breast (Edinburgh, Scotland) 33 (June): 139–44. doi:10.1016/j.breast.2017.03.017.